Safety and Efficacy Study of Omnitarg (Pertuzumab) to Treat Castration-Resistant Prostate Cancer - No Study Results Posted

Home Search Study Topics Glossary

Safety and Efficacy Study of Omnitarg (Pertuzumab) to Treat Castration-Resistant Prostate Cancer

This study has been completed.

Study NCT00058539 Information provided by Genentech

First Received: April 8, 2003 Last Updated: September 1, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2004
Estimated Primary Completion Date:	No date given